TD Capital Management’s Novo Nordisk NVO Stock Holding History

TD Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4K	Buy	217 +5	+2%	+$215	﹤0.01%	448
2026 Q1	$7.81K	Hold	212	–	–	﹤0.01%	500
2025 Q4	$10.8K	Sell	212 -582	-73%	-$29.8K	﹤0.01%	437
2025 Q3	$44.1K	Buy	794 +1	+0.1%	+$59	﹤0.01%	233
2025 Q2	$54.7K	Buy	793 +585	+281%	+$39.8K	0.01%	210
2025 Q1	$14.5K	Hold	208	–	–	﹤0.01%	285
2024 Q4	$17.9K	Hold	208	–	–	﹤0.01%	251
2024 Q3	$24.8K	Hold	208	–	–	﹤0.01%	237
2024 Q2	$29.6K	Buy	208 +2	+1%	+$265	﹤0.01%	218
2024 Q1	$26.5K	Hold	206	–	–	﹤0.01%	222
2023 Q4	$21.4K	Hold	206	–	–	﹤0.01%	242
2023 Q3	$18.8K	Hold	206	–	–	﹤0.01%	240
2023 Q2	$16.7K	Buy	206 +2	+1%	+$163	﹤0.01%	249
2023 Q1	$16.3K	Hold	204	–	–	﹤0.01%	243
2022 Q4	$13.9K	Hold	204	–	–	﹤0.01%	230
2022 Q3	$10K	Buy	+204	New	+$10.9K	﹤0.01%	238
2022 Q1	–	Sell	-202	Closed	-$11K	–	265
2021 Q4	$11K	Hold	202	–	–	﹤0.01%	260
2021 Q3	$10K	Hold	202	–	–	﹤0.01%	250
2021 Q2	$8K	Buy	202 +2	+1%	+$78	﹤0.01%	256
2021 Q1	$7K	Hold	200	–	–	﹤0.01%	240
2020 Q4	$7K	Sell	200 -800	-80%	-$27.7K	﹤0.01%	212
2020 Q3	$35K	Hold	1,000	–	–	0.01%	134
2020 Q2	$33K	Hold	1,000	–	–	0.01%	129
2020 Q1	$30K	Buy	+1,000	New	+$29.8K	0.01%	121

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

TD Capital Management's NVO Position: Q2 2026 in Review

TD Capital Management increased its Novo Nordisk (NVO) stake by 2.4% in Q2 2026, buying an estimated $215 and bringing the position to 217 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #448.

TD Capital Management first reported a position in NVO in Q1 2020 and has held it in 24 quarters since. The position peaked at $54.7K in Q2 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

TD Capital Management held 217 shares of Novo Nordisk worth $10.4K as of Q2 2026.
TD Capital Management bought 5 Novo Nordisk shares in Q2 2026, an estimated $215.
Novo Nordisk made up ﹤0.01% of TD Capital Management's portfolio in Q2 2026, its #448 holding.
TD Capital Management first reported a position in Novo Nordisk in Q1 2020 and has held it in 24 quarters since.
TD Capital Management's Novo Nordisk position peaked at $54.7K in Q2 2025.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on TD Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.